ACADIA Pharmaceuticals Inc. Net Income 2009–2025
ACADIA Pharmaceuticals Inc. reported $391.00M of net income for fiscal 2025. That was 72.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +238.9%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $391.00M | 36.5% | +72.7% |
| FY 2024 | $226.45M | 23.6% | +469.5% |
| FY 2023 | $-61.29M | -8.4% | +71.6% |
| FY 2022 | $-215.97M | -41.8% | -28.7% |
| FY 2021 | $-167.87M | -34.7% | +40.4% |
| FY 2020 | $-281.58M | -63.7% | -19.7% |
| FY 2019 | $-235.26M | -69.4% | +4.1% |
| FY 2018 | $-245.19M | -109.6% | +15.3% |
| FY 2017 | $-289.40M | -231.7% | -6.6% |
| FY 2016 | $-271.39M | -1565.9% | -65.0% |
| FY 2015 | $-164.44M | -269578.7% | -77.8% |
| FY 2014 | $-92.47M | -77062.5% | -143.7% |
| FY 2013 | $-37.95M | -3314.2% | -82.0% |
| FY 2012 | $-20.85M | -424.9% | +8.4% |
| FY 2011 | $-22.77M | -1101.4% | -250.4% |
| FY 2010 | $15.14M | 35.9% | +133.5% |
| FY 2009 | $-45.15M | -705.5% | — |
Source: ACADIA Pharmaceuticals Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ACAD 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
ACADIA Pharmaceuticals Inc. reported $391.00M of net income for fiscal 2025. That was 72.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +238.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for ACADIA Pharmaceuticals Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeACADIA Pharmaceuticals Inc. — frequently asked questions
What is ACADIA Pharmaceuticals Inc.'s net income?
ACADIA Pharmaceuticals Inc. (ACAD) reported net income of $391.00M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from ACADIA Pharmaceuticals Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.